CD274 and non-small cell lung carcinoma: Moreover, Ferrara and his colleagues focused on the occurrence of HPD in advanced NSCLC by comparing patients receiving PD‐1/PD‐L1 inhibitors with those treated with single‐agent chemotherapy.